Intellipharmaceutics Announces Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Intellipharmaceutics (IPCI) Reports Q3 Loss of $0.08/Share
October 9, 2015 7:01 AM EDTIntellipharmaceutics (NASDAQ: IPCI) reported Q3 EPS of ($0.08), versus ($0.07) reported last year. Revenue for the quarter came in at $840.8 thousand, versus $1.07 million reported last year.
For earnings history and earnings-related data on Intellipharmaceutics (IPCI) click here.
... More